Zhu Y - Search Results

1

Characteristics of TP53 germline variants and their correlations with Li-Fraumeni syndrome or Li-Fraumeni-like syndrome in Chinese tumor patients.

Tian P, Zhang X, Yang S, Fang Y, Yuan H, Li W, Zhu H, Zhao F, Ding J, Zhu Y, Wang S, Sun G, Ni H, Ma T, Lei T. Tian P, et al. Among authors: zhu h, zhu y. J Genet Genomics. 2022 Jul;49(7):645-653. doi: 10.1016/j.jgg.2021.12.012. Epub 2022 Jan 14. J Genet Genomics. 2022. PMID: 35033608

2

Nimotuzumab plus platinum-based chemotherapy versus platinum-based chemotherapy alone in patients with recurrent or metastatic nasopharyngeal carcinoma.

Zhu Y, Yang S, Zhou S, Yang J, Qin Y, Gui L, Shi Y, He X. Zhu Y, et al. Ther Adv Med Oncol. 2020 Sep 16;12:1758835920953738. doi: 10.1177/1758835920953738. eCollection 2020. Ther Adv Med Oncol. 2020. PMID: 32973932 Free PMC article.

3

Prognostic evaluation models for primary thyroid lymphoma, based on the SEER database and an external validation cohort.

Zhu Y, Yang S, He X. Zhu Y, et al. J Endocrinol Invest. 2022 Apr;45(4):815-824. doi: 10.1007/s40618-021-01712-3. Epub 2021 Dec 4. J Endocrinol Invest. 2022. PMID: 34865184 Free PMC article.

4

Establishment of a molecular risk model for the prognosis of cervical cancer based on microRNA expression.

Li J, Liang L, Xiu L, Zeng J, Zhu Y, An J, Wu L. Li J, et al. Among authors: zhu y. Ann Transl Med. 2022 Jan;10(2):125. doi: 10.21037/atm-21-6451. Ann Transl Med. 2022. PMID: 35282101 Free PMC article.

5

Establishing Molecular Subgroups of CD8+ T Cell-Associated Genes in the Ovarian Cancer Tumour Microenvironment and Predicting the Immunotherapy Response.

Zhu Y, Liang L, Li J, Zeng J, Yao H, Wu L. Zhu Y, et al. Biomedicines. 2023 Aug 28;11(9):2399. doi: 10.3390/biomedicines11092399. Biomedicines. 2023. PMID: 37760841 Free PMC article.

6

ALKBH5-mediated m6A modification of circCCDC134 facilitates cervical cancer metastasis by enhancing HIF1A transcription.

Liang L, Zhu Y, Li J, Zeng J, Wu L. Liang L, et al. Among authors: zhu y. J Exp Clin Cancer Res. 2022 Aug 26;41(1):261. doi: 10.1186/s13046-022-02462-7. J Exp Clin Cancer Res. 2022. PMID: 36028854 Free PMC article.

7

Immune Subtypes and Immune Landscape Analysis of Endometrial Carcinoma.

Liang L, Zhu Y, Li J, Zeng J, Yuan G, Wu L. Liang L, et al. Among authors: zhu y. J Immunol. 2022 Oct 15;209(8):1606-1614. doi: 10.4049/jimmunol.2200329. Epub 2022 Sep 12. J Immunol. 2022. PMID: 36096644 Free PMC article.

8

CircNUP50 is a novel therapeutic target that promotes cisplatin resistance in ovarian cancer by modulating p53 ubiquitination.

Zhu Y, Liang L, Zhao Y, Li J, Zeng J, Yuan Y, Li N, Wu L. Zhu Y, et al. J Nanobiotechnology. 2024 Jan 19;22(1):35. doi: 10.1186/s12951-024-02295-w. J Nanobiotechnology. 2024. PMID: 38243224 Free PMC article.

9

Multiple gene-deletion vaccinia virus Tiantan strain against mpox.

Zhu Y, Li D, Zhao R, Chen M, Li Y, Yang X, Mao H, Li X, Li Y, Shang C, Xia X. Zhu Y, et al. Virol J. 2025 Jan 25;22(1):17. doi: 10.1186/s12985-025-02629-6. Virol J. 2025. PMID: 39863910 Free article.

10

MAPK4 inhibits the early aberrant activation of B cells in rheumatoid arthritis by promoting the IRF4-SHIP1 signaling pathway.

Huang P, Yang G, Zhang P, Zhu Y, Guan Y, Sun J, Li Q, An Y, Shi X, Zhao J, Liu C, He Z, Chen Y, Du Z. Huang P, et al. Among authors: zhu y. Cell Death Dis. 2025 Jan 26;16(1):43. doi: 10.1038/s41419-025-07352-2. Cell Death Dis. 2025. PMID: 39863600 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

55,324 results

Search Page

Filters